(Q37385890)

20 August 2017

1 reference

title

Is TRAIL the holy grail of cancer therapy? (English)

1 reference

20 August 2017

Thomas Newsom-Davis

1

1 reference

PubMed ID

19194800

20 August 2017

Silvia Prieske

series ordinal

2

1 reference

PubMed ID

19194800

20 August 2017

Henning Walczak

series ordinal

3

1 reference

20 August 2017

1 April 2009

1 reference

20 August 2017

1 reference

20 August 2017

14

1 reference

20 August 2017

607-623

1 reference

20 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s10495-009-0321-2

20 August 2017

0 references

cites work

Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice

1 reference

https://api.crossref.org/works/10.1007%2FS10495-009-0321-2

TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-009-0321-2

Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-009-0321-2

Selective Inhibition of I B Kinase Sensitizes Mantle Cell Lymphoma B Cells to TRAIL by Decreasing Cellular FLIP Level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-009-0321-2

TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-009-0321-2

10.1007/S10495-009-0321-2

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19194800